NCT03436433View on ClinicalTrials.gov

Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

PHASE2TerminatedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

December 4, 2020

Study Completion Date

December 4, 2020

Conditions

GliomaGlioma of BrainBrain Tumor

Interventions

DRUG

Lacosamide

LCM 100mg twice a day.

DRUG

Levetiracetam

LEV 1000mg twice a day.

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT03436433 - Seizure Prophylaxis in Patients With Glioma or Brain Metastasis | Biotech Hunter | Biotech Hunter